The Quest for Anti-inflammatory and Anti-infective Biomaterials in Clinical Translation.
Biomaterials are now being used or evaluated clinically as implants to supplement the severe shortage of available human donor organs. To date, however, such implants have mainly been developed as scaffolds to promote the regeneration of failing organs due to old age or congenital malformations. In the real world, however, infection or immunological issues often compromise patients. For example, bacterial and viral infections can result in uncontrolled immunopathological damage and lead to organ failure. Hence, there is a need for biomaterials and implants that not only promote regeneration but also address issues that are specific to compromised patients, such as infection and inflammation. Different strategies are needed to address the regeneration of organs that have been damaged by infection or inflammation for successful clinical translation. Therefore, the real quest is for multifunctional biomaterials with combined properties that can combat infections, modulate inflammation, and promote regeneration at the same time. These strategies will necessitate the inclusion of methodologies for management of the cellular and signaling components elicited within the local microenvironment. In the development of such biomaterials, strategies range from the inclusion of materials that have intrinsic anti-inflammatory properties, such as the synthetic lipid polymer, 2-methacryloyloxyethyl phosphorylcholine (MPC), to silver nanoparticles that have antibacterial properties, to inclusion of nano- and micro-particles in biomaterials composites that deliver active drugs. In this present review, we present examples of both kinds of materials in each group along with their pros and cons. Thus, as a promising next generation strategy to aid or replace tissue/organ transplantation, an integrated smart programmable platform is needed for regenerative medicine applications to create and/or restore normal function at the cell and tissue levels. Therefore, now it is of utmost importance to develop integrative biomaterials based on multifunctional biopolymers and nanosystem for their practical and successful clinical translation.
Department of Clinical and Experimental Medicine (IKE), Linköping University, Linköping, Sweden; Department of Neuroscience, Swedish Medical Nanoscience Center, Karolinska Institutet, Stockholm, Sweden; Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Center, University of Montreal, Montreal, QC, Canada.
May
M
Griffith
Department of Clinical and Experimental Medicine (IKE), Linköping University, Linköping, Sweden; Department of Neuroscience, Swedish Medical Nanoscience Center, Karolinska Institutet, Stockholm, Sweden.
Mohammad M
MM
Islam
Department of Clinical and Experimental Medicine (IKE), Linköping University, Linköping, Sweden; Department of Neuroscience, Swedish Medical Nanoscience Center, Karolinska Institutet, Stockholm, Sweden.
Joel
J
Edin
Department of Clinical and Experimental Medicine (IKE), Linköping University , Linköping , Sweden.
Georgia
G
Papapavlou
Department of Eye Burns, Ophthalmic Reconstructive Surgery, Keratoplasty and Keratoprosthesis, Filatov Institute of Eye diseases and Tissue Therapy of the NAMS of Ukraine , Odessa , Ukraine.
Oleksiy
O
Buznyk
Department of Clinical and Experimental Medicine (IKE), Linköping University , Linköping , Sweden.
Hirak K
HK
Patra
anti-infective; anti-inflammatory; biomaterials; clinical translation
Retin Cases Brief Rep. 2017 Winter;11(1):51-55
26982209
Beilstein J Org Chem. 2014 Jun 12;10:1339-46
24991287
Nanoscale. 2016 Mar 28;8(12):6484-9
26949000
Annu Rev Med. 2001;52:443-51
11160788
Biochem Biophys Res Commun. 2013 Jan 11;430(2):519-22
23232115
Mediators Inflamm. 2014;2014:805841
25505823
N Engl J Med. 2004 Aug 19;351(8):751-9
15317888
J Cell Physiol. 2014 Aug;229(8):984-9
24347365
Biomatter. 2012 Oct-Dec;2(4):226-36
23507888
J Biomed Mater Res A. 2014 May;102(5):1527-36
23765644
Mater Sci Eng C Mater Biol Appl. 2014 Jun 1;39:177-85
24863214
N Engl J Med. 2003 May 15;348(20):1948-51
12748314
Nanomedicine. 2012 Jan;8(1):37-45
21703988
Chemistry. 2009 Sep 28;15(38):9874-88
19681073
Biomaterials. 2010 Jan;31(2):308-14
19782393
J Biol Chem. 2015 Jan 2;290(1):529-43
25371202
Biomacromolecules. 2014 Jul 14;15(7):2359-68
24813544
Bioorg Med Chem Lett. 2010 May 1;20(9):2718-21
20382017
Glycobiology. 2003 Jun;13(6):29R-40R
12626402
J Biomed Mater Res A. 2015 Feb;103(2):555-63
24753309
Int J Nanomedicine. 2012;7:6003-9
23233805
J Cell Mol Med. 2013 Apr;17(4):518-30
23480821
J Nanobiotechnology. 2010 Aug 18;8:19
20718972
Biomater Sci. 2014 Apr 4;2(4):502-511
32481988
Materials (Basel). 2013 Jun 05;6(6):2295-2350
28809275
Nat Nanotechnol. 2007 Aug;2(8):469-78
18654343
Chem Biol. 2005 Oct;12(10):1127-35
16242655
J Gastroenterol. 2004;39(4):346-54
15168246
Clin Ophthalmol. 2015 Jul 16;9:1321-35
26213460
Nanotoxicology. 2014 Feb;8(1):1-16
23092443
J Nanobiotechnology. 2005 Jun 29;3:6
15987516
Semin Immunol. 2008 Apr;20(2):86-100
18162407
Transl Vis Sci Technol. 2014 May 29;3(3):4
24932432
Biomaterials. 2007 Apr;28(10):1778-86
17204321
J Zhejiang Univ Sci B. 2008 Jun;9(6):506-10
18543406
Clin Transl Sci. 2015 Oct;8(5):558-62
25996570
Adv Drug Deliv Rev. 2013 Apr;65(4):581-603
22820527
Pharmacol Rep. 2012;64(2):282-92
22661177
J Med Invest. 2010 Feb;57(1-2):26-34
20299740
Cell Transplant. 1995 Sep-Oct;4(5):455-77
8520830
J Nanomed Nanotechnol. 2011 Apr 1;2(2):1-9
21743839
Curr HIV Res. 2010 Jul;8(5):396-404
20426757
Nanoscale Res Lett. 2013 Feb 20;8(1):93
23421446
Nanoscale. 2015 Nov 28;7(44):18789-98
26507748
Curr Med Chem. 2004 Sep;11(18):2399-419
15379705
Biomaterials. 2010 Sep;31(25):6363-77
20542556
Eur J Pharm Biopharm. 2012 Jan;80(1):103-12
22005155
Acta Biomater. 2005 Nov;1(6):691-703
16701850
J Virol Methods. 2011 Dec;178(1-2):137-42
21945220
Biomaterials. 2009 Feb;30(5):730-5
19038442
Small. 2010 May 7;6(9):1044-50
20394070
Int J Nanomedicine. 2013;8:4303-14
24235828
Appl Microbiol Biotechnol. 2012 Jan;93(1):71-82
22089385
J Am Chem Soc. 2008 Jun 4;130(22):6896-7
18473457
Biomaterials. 2012 Feb;33(5):1303-14
22078809
Genet Mol Res. 2014 Mar 19;13(3):7022-8
24682984
Biomaterials. 2010 May;31(14):3997-4008
20185171
Molecules. 2015 Jan 07;20(1):738-53
25574818
Environ Sci Technol. 2011 Feb 15;45(4):1177-83
21218770
J Nanobiotechnology. 2010 Jan 20;8:1
20145735
Ophthalmology. 2014 Oct;121(10):1871-6
24907061
Bioorg Med Chem. 2006 Sep 1;14(17):5989-94
16725329
Orthopedics. 2012 Aug 1;35(8):679-81
22868589
Materials (Basel). 2014 May 19;7(5):3946-3955
28788658
Food Chem Toxicol. 2011 Aug;49(8):1745-52
21570441
Small. 2013 Aug 26;9(16):2735-46
23463684
Bioconjug Chem. 2012 Apr 18;23(4):814-25
22433013
Biotechnol Appl Biochem. 1990 Jun;12(3):315-24
1694440
J Ind Microbiol Biotechnol. 2006 Jul;33(7):627-34
16761169
J Bone Joint Surg Am. 2007 Sep;89(9):2044-7
17768205
J Appl Microbiol. 2016 Mar;120(3):527-42
26599354
Biomaterials. 2004 Aug;25(18):4383-91
15046929
Biomaterials. 2012 Jan;33(1):304-16
22019155
ACS Appl Mater Interfaces. 2015 Nov 18;7(45):25487-94
26512953
Polymers (Basel). 2014 Sep 29;6(10):2526-2551
25705515
IET Nanobiotechnol. 2015 Jun;9(3):107-13
26023154
Burns. 2010 Sep;36(6):751-8
20346592
Sci Transl Med. 2012 Sep 26;4(153):153rv10
23019658
Trends Biotechnol. 2016 Dec;34(12):945-948
27344424